Replies to post #33000 on Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

According to the study that Cornerstone Penny Stock Marketing quoted in his post without actually reading the results, SofPulse doesn't work. It works about as effectively as a placebo.

From the Last 10Q,

During the three months ended March 31, 2023, the Company has raised $0.2 million in equity financing through the issuance of common shares under a private offering.

ENDV raised $200,000 in cash yet it ended the quarter with only $11,000 in cash. Where is that money going? Collier is using investor cash to pay himself and his buddies. Besides paying the accountants and lawyers, this company cannot fund anything let alone an actual business.